alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 20,601–20,625 of 27,380 studies, newest first · page 825 of 1096.

September 2010 12

  1. 2010-09-01

    The word processing deficit in semantic dementia: all categories are equal, but some categories are more equal than others

    ✓ Peer-reviewed Digital health tools Journal of cognitive neuroscience

    Key finding: Furthermore, this specific pattern of deficits cannot be captured by classic category distinctions such as nouns versus verbs or living versus nonliving things. +1 more finding

    Full summary, score breakdown and related studies → Original source

  2. 2010-09-01

    Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants

    ✓ Peer-reviewed Digital health tools Brain : a journal of neurology

    Key finding: Prospective studies have shown that although the beneficial effects of this procedure are maintained at 5 years, axial motor features and cognitive decline may occur in the long term after the implants. +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2010-09-01

    Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K

    ✓ Peer-reviewed How common it is The British journal of dermatology

    Key finding: Severe psoriasis is associated with an increased risk of death from a variety of causes, with cardiovascular death being the most common aetiology. +3 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2010-09-01

    Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis

    ✓ Peer-reviewed How common it is Neurology

    Key finding: MCI is common in patients with PD without dementia, affecting a range of cognitive domains, including memory, visual-spatial, and attention/executive abilities. +1 more finding

    Full summary, score breakdown and related studies → Original source

  5. 2010-09-01

    A biobehavioral home-based intervention and the well-being of patients with dementia and their caregivers: the COPE randomized trial

    ✓ Peer-reviewed Caregiving JAMA

    Key finding: Among community-living dyads, a nonpharmacologic biobehavioral environmental intervention compared with control resulted in better outcomes for COPE dyads at 4 months. +2 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2010-09-01

    Distinct cerebral perfusion patterns in FTLD and AD

    ✓ Peer-reviewed Brain scans and imaging Neurology

    Key finding: Doubly dissociated areas of hypoperfusion in FTLD and AD are consistent with areas of significant histopathologic burden in these groups. +4 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2010-09-01

    18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial

    ✓ Peer-reviewed Brain scans and imaging Annals of neurology

    Key finding: (18)F-Flutemetamol performs similarly to the (11)C-PIB parent molecule within the same subjects and provides high test-retest replicability and potentially much wider accessibility for clinical and research use. +2 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2010-09-01

    Older patients in the emergency department: a review

    ✓ Peer-reviewed Getting a diagnosis Annals of emergency medicine

    Key finding: Increased frailty, delayed diagnosis, and greater illness severity contribute to a higher risk of adverse outcomes.

    Full summary, score breakdown and related studies → Original source

  9. 2010-09-01

    Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging

    ✓ Peer-reviewed Getting a diagnosis Neurology

    Key finding: Among 1,969 subjects without dementia, 329 subjects had MCI, with a prevalence of 16.0% (95% confidence interval [CI] 14.4-17.5) for any MCI, 11.1% (95% CI 9.8-12.3) for amnestic MCI, and 4.9% (95% CI 4.0-5.8) for nonamnestic MCI. +2 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2010-09-01

    Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke

    ✓ Peer-reviewed Prevention and risk The Lancet. Neurology

    Key finding: Cognitive dysfunction ranges from focal deficits, resulting directly from an area of infarction or from hypoperfusion in adjacent tissue, to more global cognitive dysfunction. +4 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2010-09-01

    A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2

    ✓ Peer-reviewed Genetics Neurology

    Key finding: This comprehensive population genetic study in control subjects fills the void for a PARK2 reference dataset. +2 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2010-09-01

    A serum protein-based algorithm for the detection of Alzheimer disease

    ✓ Peer-reviewed Genetics Archives of neurology

    Key finding: These initial data suggest that serum protein-based biomarkers can be combined with clinical information to accurately classify AD. +2 more findings

    Full summary, score breakdown and related studies → Original source

August 2010 13

  1. 2010-08-27

    Encephalopathies: the emerging diabetic complications

    ✓ Peer-reviewed Brain scans and imaging Acta diabetologica

    Key finding: The increased incidence of Alzheimer's disease in type 2 diabetes is associated with insulin resistance, hyperinsulinemia and hyperglycemia, and commonly accompanying attributes such as hypercholesterolemia, hypertension and obesity. +1 more finding

    Full summary, score breakdown and related studies → Original source

  2. 2010-08-25

    Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 mice

    ✓ Peer-reviewed Risk genes beyond APOE The Journal of biological chemistry

    Key finding: Previously, we showed that human apolipoprotein A-I (apoA-I) decreases Aβ(40) aggregation and toxicity. +3 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2010-08-25

    Cognitive impairment and 7-year mortality in dialysis patients

    ✓ Peer-reviewed Prevention and risk American journal of kidney diseases : the official journal of the National Kidney Foundation

    Key finding: Cognitive impairment is an independent predictor of mortality in dialysis patients. +2 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2010-08-25

    ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice

    ✓ Peer-reviewed Genetics The Journal of biological chemistry

    Key finding: ABCA1 was required to observe significantly elevated apoE levels in brain tissue and cerebrospinal fluid upon therapeutic (33 mg/kg/day) GW3965 treatment. +2 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2010-08-25

    Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study

    ✓ Peer-reviewed Genetics Neurology

    Key finding: The results of this study suggest that hyperinsulinemia and hyperglycemia caused by insulin resistance accelerate NP formation in combination with the effects of APOE epsilon4. +1 more finding

    Full summary, score breakdown and related studies → Original source

  6. 2010-08-25

    Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study

    ✓ Peer-reviewed Genetics Neurology

    Key finding: Elderly patients with diabetes develop more extensive vascular pathology, which alone or together with AD-type pathology (particularly in APOE ε4 carriers) results in increased dementia risk. +1 more finding

    Full summary, score breakdown and related studies → Original source

  7. 2010-08-23

    The Amazonian herbal Marapuama attenuates cognitive impairment and neuroglial degeneration in a mouse Alzheimer model

    ✓ Peer-reviewed Biomarkers Phytomedicine : international journal of phytotherapy and phytopharmacology

    Key finding: This study offers evidence of functional and neuroprotective effects of two weeks treatment with a Ptychopetalum olacoides extract against Aβ peptide-induced neurotoxicity in mice.

    Full summary, score breakdown and related studies → Original source

  8. 2010-08-22

    Metals, oxidative stress and neurodegenerative disorders

    ✓ Peer-reviewed Inflammation and the immune system Molecular and cellular biochemistry

    Key finding: Biochemical analysis of amyloid plaques revealed that the main constituent is fibrillar aggregates of a 39-42 residue peptide referred to as the amyloid-β protein (Aβ). +2 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2010-08-22

    A neuroimaging investigation of the association between aerobic fitness, hippocampal volume, and memory performance in preadolescent children

    ✓ Peer-reviewed Hippocampus size on brain scans Brain research

    Key finding: Animal research has indicated that aerobic exercise is related to increased cell proliferation and survival in the hippocampus as well as enhanced hippocampal-dependent learning and memory. +4 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2010-08-21

    Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study

    ✓ Peer-reviewed Treatments Dementia and geriatric cognitive disorders

    Key finding: No evidence of efficacy of 2 mg or 8 mg RSG XR monotherapy in cognition or global function was detected in the APOE-ε4-negative or other analysis populations. +1 more finding

    Full summary, score breakdown and related studies → Original source

  11. 2010-08-20

    Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

    ✓ Peer-reviewed Treatments The Lancet. Neurology

    Key finding: No significant differences were noted between the two treatments in patients with PDD (3·6 with memantine vs 3·8 with placebo, -0·1 [-0·6 to 0·3]; p=0·576) or in the total population (3·5 with memantine vs 3·8 with placebo, -0·3 [-0·7 to 0·1]; p=0·120). +3 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2010-08-19

    Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats

    ✓ Peer-reviewed Drug development Neuroscience

    Key finding: The results showed that (1) Aβ1-40 (5 nmol) injection did not affect the baseline field excitatory postsynaptic potentials (fEPSPs), but significantly suppressed multiple high frequency stimulation (HFS)-induced L-LTP in hippocampal CA1 region; (2) Val(8)-GLP-1(7-36) (0.05 pmol) administration alone did not affect the baseline synaptic transmission and the maintenance of L-LTP; (3) pretreatment with Val(8)-GLP-1(7-36) (0.05 pmol) effectively prevented Aβ1-40-induced deficit of L-LTP; (4) i.c.v. injection of 5 nmol Aβ1-40 resulted in a significant decline learning a spatial Morris water maze (MWM) test; (5) Val(8)-GLP-1(7-36) (0.05 pmol) administration alone did not affect spatial learning in this task, while pretreatment with Val(8)-GLP-1(7-36) effectively reversed the impairment of spatial learning and memory induced by Aβ1-40. +1 more finding

    Full summary, score breakdown and related studies → Original source

  13. 2010-08-18

    A systematic review of the prevalence, associations and outcomes of dementia in older general hospital inpatients

    ✓ Peer-reviewed Clinical safety International psychogeriatrics

    Key finding: When planning liaison services, the setting and demographic features of the population need to be taken into account. +4 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →